158 related articles for article (PubMed ID: 24962657)
1. Shape analysis of the prostate: establishing imaging specifications for the design of a transurethral imaging device for prostate brachytherapy guidance.
Holmes DR; Davis BJ; Goulet CC; Wilson TM; Mynderse LA; Furutani KM; Camp JJ; Robb RA
Brachytherapy; 2014; 13(5):465-70. PubMed ID: 24962657
[TBL] [Abstract][Full Text] [Related]
2. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
4. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
6. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
Foster W; Cunha JA; Hsu IC; Weinberg V; Krishnamurthy D; Pouliot J
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):85-90. PubMed ID: 20605353
[TBL] [Abstract][Full Text] [Related]
8. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
9. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy.
Sanders JW; Lewis GD; Thames HD; Kudchadker RJ; Venkatesan AM; Bruno TL; Ma J; Pagel MD; Frank SJ
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1292-1303. PubMed ID: 32634543
[TBL] [Abstract][Full Text] [Related]
10. Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy.
Kirisits C; Goldner G; Berger D; Georg D; Pötter R
Brachytherapy; 2009; 8(4):353-60. PubMed ID: 19446499
[TBL] [Abstract][Full Text] [Related]
11. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
[TBL] [Abstract][Full Text] [Related]
12. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
[TBL] [Abstract][Full Text] [Related]
14. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
[TBL] [Abstract][Full Text] [Related]
15. Dose to the bladder neck is not correlated with urinary toxicity in patients with prostate cancer treated with HDR brachytherapy boost.
Ben Aicha I; Hathout L; Carignan D; Després P; Lavallée MC; Aubin S; Beaulieu L; Lacroix F; Foster W; Martin AG; Vigneault E
Brachytherapy; 2020; 19(5):584-588. PubMed ID: 32928485
[TBL] [Abstract][Full Text] [Related]
16. A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy.
Halperin H; Hilts M; Crook J; Batchelar D; Tisseverasinghe S; Tetreault-LaFlamme A; Bachand F
Brachytherapy; 2019; 18(5):675-682. PubMed ID: 31248822
[TBL] [Abstract][Full Text] [Related]
17. Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.
Waterman FM; Dicker AP
Med Phys; 2000 Mar; 27(3):448-51. PubMed ID: 10757596
[TBL] [Abstract][Full Text] [Related]
18. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
19. Is tissue harmonic ultrasound imaging (THI) of the prostatic urethra and rectum superior to brightness (B) mode imaging? An observer study.
Sandhu GK; Angyalfi S; Dunscombe PB; Khan RF
Phys Med; 2014 Sep; 30(6):662-8. PubMed ID: 24792688
[TBL] [Abstract][Full Text] [Related]
20. Is the use of a surrogate urethra an option in prostate high-dose-rate brachytherapy?
Nilsson J; Kälkner KM; Berg L; Levitt S; Holmberg C; Nilsson S; Lundell M
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):36-40. PubMed ID: 17980507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
